the market?
Alimera Sciences, Inc.
NASDAQ: ALIM
4.18
-0.10
(-2.34%)
| Today's Open | $4.25 |
|---|---|
| Previous Close | $4.28 |
| Daily Range | $3.85 - $4.47 |
| 52-Week Range | $1.26 - $5.10 |
| Market Cap | $132.0M |
| P/E Ratio | -4.60 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 229,247 |
| Average Daily Volume | 89,154 |
| Current FY EPS | $0.00 |
How do you think ALIM
will perform against the market?
Top ALIM Bull/Bear Pitches
TSIF (< 20)
Submitted
November 13, 2011
Alimera Sciences, Inc got the dreaded "complete response letter" from the FDA, meaning that it's drug approval under consideration was denied. These can come in several forms. A hard kill … More
zzlangerhans (< 20)
Submitted
December 14, 2011
I'm somewhat obligated to keep tracking Alimera on CAPS, if for no reason other than to take my mea culpa on recommending it (and buying it) prior to their horrendous PDUFA faceplant last month. I've … More
News & Commentary
After-Hours Earnings Report for March 21, 2013 : NKE, SLW, MU, TIBX, RUE, NWY, ALIM
After-Hours Earnings Report for March 21, 2013 : NKE, SLW, MU, TIBX, RUE, NWY, ALIMStocks Avoiding the Doom and Gloom of Europe
These stocks just took off, but are they about to make a return trip to Earth?Upgrades & Downgrades: More Woe for Wal-Mart
Wall Street ratings agencies set the tone for today's stock market.24/7 Wall St. Closing Bell (JNJ, KSS, WTW, DHI, LEN, TOL, ACI, ALIM, ZUMZ, ARO, ANN, CCL, FGP, HALO,
24/7 Wall St. Closing Bell (JNJ, KSS, WTW, DHI, LEN, TOL, ACI, ALIM, ZUMZ, ARO, ANN, CCL, FGP, HALO, URRE, JVA, QSFT, ASTM, DYN, ZGNX, GMCR)Alimera Annihilates Its Doubters
European approval of Iluvien sends shares skyrocketing.24/7 Wall St. Closing Bell (AAPL, NEM, DNDN, CHTR, APOL, COST, PCLN, HFC, AZO, CRZO, DPZ, ODP, SAFM,
24/7 Wall St. Closing Bell (AAPL, NEM, DNDN, CHTR, APOL, COST, PCLN, HFC, AZO, CRZO, DPZ, ODP, SAFM, RDC, TECD, YRCW, ALIM, TBET, SUMR, PEIX, CECO)Sector
Healthcare
Industry
Drugs
Alimera Sciences, Inc. (ALIM) Description
Alimera Sciences Inc. is a biopharmaceutical company that engaged in the research development and commercialization of ophthalmic pharmaceuticals. Website: http://www.alimerasciences.com/
